• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSL0500005 30/70双时相低精蛋白锌重组人胰岛素注射液 human insulin;isophane protamine human insulin Injection Biological Products(15) Generic Drug 2005-08-24 江苏万邦生化医药股份有限公司 Wanbang Biopharmaceuticals Certificate Issued 2006-07-12 view
CYSS0690004 30/70双时相低精蛋白锌重组人胰岛素注射液 human insulin;isophane protamine human insulin Injection Biological Products(15) Generic Drug 2006-10-23 江苏万邦生化医药股份有限公司 Wanbang Biopharmaceuticals Certificate Issued 2010-03-11 view
CYSS0600071 30/70双时相低精蛋白锌重组人胰岛素注射液 human insulin;isophane protamine human insulin Injection Biological Products(15) Generic Drug 2006-08-08 江苏万邦生化医药股份有限公司 Wanbang Biopharmaceuticals Certificate Issued 2007-09-19 view
CXSL2400530 精蛋白人胰岛素混合注射液 (30R) human insulin;isophane protamine human insulin Injection Biological Products(3.3) New Drug Application 2024-08-10 Virtu Pharmako (Zhejiang) Co Ltd view
JYSZ2200026 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2022-06-24 view
CYSB2200024 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2022-01-26 Novo Nordisk (China) Pharmaceuticals Co Ltd view
CYSB2300203 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2023-11-03 Novo Nordisk (China) Pharmaceuticals Co Ltd view
JYSB2000671 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-28 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view
JYSZ2100516 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2021-05-12 view
JYSB2000669 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-28 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view
CYSB2101062 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-05-19 Zhuhai United Laboratories Co Ltd view
CYSB2101174 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-09-02 Zhuhai United Laboratories Co Ltd view
JYSB2101175 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-11-29 Lilly France view
JYSZ2200061 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2022-11-08 view
JYSB2000661 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-25 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view
CYSB2200233 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2022-09-23 Gan & Lee Pharmaceuticals view
JYSZ2200062 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2022-11-08 view
CXSS2200010 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products(3.3) New Drug Application 2022-01-28 Yichang HEC Changjiang Pharmaceutical Co Ltd view
JYSB2000670 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-28 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view
JYSZ2100508 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2021-04-21 view